Immunocore Holdings (IMCR) Inventory Average (2024 - 2026)
Immunocore Holdings' (IMCR) quarterly Inventory Average came in at $7.5 million in Q1 2026, up 22.41% year-on-year from $6.1 million in Q1 2025, and up 20.96% quarter-over-quarter from $6.2 million in Q4 2025.
Immunocore Holdings (IMCR) Inventory Average (2024 - 2026) Analysis & Trends
Immunocore Holdings has disclosed Inventory Average across 3 years of filings, most recently posting $7.5 million for Q1 2026.
- Inventory Average for Q1 2026 came in at $7.5 million, up 22.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.5 million (up 22.41% YoY), and the FY2025 annual result was $6.1 million, up 22.53% from the prior year.
- Inventory Average came in at $7.5 million for Q1 2026 at Immunocore Holdings, up from $6.2 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $7.5 million in Q1 2026 to a low of $3.8 million in Q2 2024.
- The 3-year median for Inventory Average is $5.6 million (2025), against an average of $5.4 million.
- Across the five-year window, Inventory Average soared 60.7% in 2025 and grew 22.41% in 2026, its largest moves.
- Immunocore Holdings' Inventory Average stood at $5.0 million in 2024, then climbed by 24.42% to $6.2 million in 2025, then gained by 20.96% to $7.5 million in 2026.
- The last three Inventory Average figures came in at $7.5 million (Q1 2026), $6.2 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Immunocore Holdings | 1.46 Bn | 616.35 Mn | 106.24 Mn | 7.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.50 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | 5.56 Mn |
| Jun 30, 2025 | 6.13 Mn |
| Mar 31, 2025 | 6.13 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Sep 30, 2024 | 3.99 Mn |
| Jun 30, 2024 | 3.81 Mn |
| Mar 31, 2024 | 4.33 Mn |